170 related articles for article (PubMed ID: 21128069)
21. Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
Loureiro M; Kramar C; Renard J; Rosen LG; Laviolette SR
Biol Psychiatry; 2016 Aug; 80(3):216-25. PubMed ID: 26681496
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5-HT(1B) receptor ligands microinjected into the accumbal shell or core on the sensitization to cocaine in rats.
Przegaliński E; Siwanowicz J; Papla I; Filip M
Eur Neuropsychopharmacol; 2002 Oct; 12(5):387-96. PubMed ID: 12208556
[TBL] [Abstract][Full Text] [Related]
23. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
[TBL] [Abstract][Full Text] [Related]
24. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
Alvarez-Jaimes L; Polis I; Parsons LH
Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
[TBL] [Abstract][Full Text] [Related]
26. The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.
Thiemann G; Di Marzo V; Molleman A; Hasenöhrl RU
Pharmacol Biochem Behav; 2008 May; 89(3):384-91. PubMed ID: 18294680
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.
Xi ZX; Gilbert JG; Peng XQ; Pak AC; Li X; Gardner EL
J Neurosci; 2006 Aug; 26(33):8531-6. PubMed ID: 16914679
[TBL] [Abstract][Full Text] [Related]
28. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization.
De Vries TJ; Cools AR; Shippenberg TS
Neuroreport; 1998 Jun; 9(8):1763-8. PubMed ID: 9665597
[TBL] [Abstract][Full Text] [Related]
29. Modulatory role of the intra-accumbal CB1 receptor in protein level of the c-fos and pCREB/CREB ratio in the nucleus accumbens and ventral tegmental area in extinction and morphine seeking in the rats.
Khaleghzadeh-Ahangar H; Khodagholi F; Shaerzadeh F; Haghparast A
Brain Res Bull; 2018 Sep; 142():320-327. PubMed ID: 30170186
[TBL] [Abstract][Full Text] [Related]
30. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions.
Orio L; Edwards S; George O; Parsons LH; Koob GF
J Neurosci; 2009 Apr; 29(15):4846-57. PubMed ID: 19369553
[TBL] [Abstract][Full Text] [Related]
31. CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Schlosburg JE; O'Neal ST; Conrad DH; Lichtman AH
Psychopharmacology (Berl); 2011 Aug; 216(3):323-31. PubMed ID: 21340468
[TBL] [Abstract][Full Text] [Related]
32. Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.
Loewinger GC; Beckert MV; Tejeda HA; Cheer JF
Neuropharmacology; 2012 Jun; 62(7):2192-201. PubMed ID: 22306525
[TBL] [Abstract][Full Text] [Related]
33. Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.
Wallace DR; Mactutus CF; Booze RM
Synapse; 1996 Jul; 23(3):152-63. PubMed ID: 8807743
[TBL] [Abstract][Full Text] [Related]
34. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.
Morra JT; Glick SD; Cheer JF
Neuropharmacology; 2012 Sep; 63(4):565-74. PubMed ID: 22609048
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
[TBL] [Abstract][Full Text] [Related]
37. Significance of cannabinoid CB1 receptors in improgan antinociception.
Gehani NC; Nalwalk JW; Razdan RK; Martin BR; Sun X; Wentland M; Abood ME; Hough LB
J Pain; 2007 Nov; 8(11):850-60. PubMed ID: 17644043
[TBL] [Abstract][Full Text] [Related]
38. Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine.
Khaleghzadeh-Ahangar H; Haghparast A
Physiol Behav; 2015 Oct; 149():212-9. PubMed ID: 26057574
[TBL] [Abstract][Full Text] [Related]
39. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.
Corbillé AG; Valjent E; Marsicano G; Ledent C; Lutz B; Hervé D; Girault JA
J Neurosci; 2007 Jun; 27(26):6937-47. PubMed ID: 17596442
[TBL] [Abstract][Full Text] [Related]
40. Post-sensitization treatment with rimonabant blocks the expression of cocaine-induced behavioral sensitization and c-Fos protein in mice.
Marinho EAV; Oliveira-Lima AJ; Yokoyama TS; Santos-Baldaia R; Ribeiro LTC; Baldaia MA; da Silva RW; Hollais AW; Talhati F; Longo BM; Berro LF; Frussa-Filho R
Pharmacol Biochem Behav; 2017 May; 156():16-23. PubMed ID: 28366798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
